Cancer Research Donn Young  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kataoka, H.
Right arrow Articles by Riabowol, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kataoka, H.
Right arrow Articles by Riabowol, K.
[Cancer Research 63, 5785-5792, September 15, 2003]
© 2003 American Association for Cancer Research


Regular Articles

ING1 Represses Transcription by Direct DNA Binding and through Effects on p531

Hiromi Kataoka, Paul Bonnefin, Diego Vieyra, Xiaolan Feng, Yasuo Hara, Yutaka Miura, Takashi Joh, Hidekazu Nakabayashi, Homayoun Vaziri, Curtis C. Harris and Karl Riabowol2

Departments of Biochemistry and Molecular Biology and Oncology, University of Calgary, Calgary, Alberta, T2N 4N1 Canada [H. K., P. B., D. V., X. F., Y. H., K. R.]; Molecular Neurobiology [Y. M.] and Department of Internal Medicine and Bioregulation [T. J.], Nagoya City University Graduate School of Medical Sciences, Nagoya, 467-8601 Japan; Department of Biochemistry Hokkaido University Graduate School of Medicine, Sapporo, 060-8638 Japan [H. N.]; Ontario Cancer Institute, Toronto, Ontario, M5G 2M9 Canada [H. V.]; and National Cancer Institute, NIH, Bethesda, Maryland 20892 [C. C. H.]

The ING family of proteins is involved in the regulation of diverse processes ranging from cell cycle and cellular senescence to apoptosis. These effects are most likely through activation of acetylation-dependent pathways that ultimately alter gene expression. Despite reports linking ING to p53 activation, the molecular basis of how ING activates p53 function has not been elucidated. In this study, we found that a subset of ING family members strongly repressed human {alpha}-fetoprotein (AFP) promoter activity but stimulated the p21WAF1 promoter in parallel experiments in the same cell type, similar to the effects of p53. The p47ING1a isoform also repressed AFP promoter activity, but in contrast to other ING isoforms, it repressed the p21WAF1 promoter. p47ING3 up-regulated p21WAF1 promoter activity, but it did not have any effect on the AFP promoter. ING1b and ING2 also repressed the AFP promoter in Hep3B p53-null cell lines, and p53 coexpression enhanced this transcriptional repression. Suppression of AFP gene transcription by ING was strongly dependent on AT-motifs that bind to the hepatocyte nuclear factor 1 (HNF1) transcription factor. Indeed, electrophoretic mobility shift assays confirmed that HNF1 binds to AT-motifs, but we found, surprisingly, that the ING1 complexes binding to these AT-motifs were devoid of HNF1 protein. Both ING1 and p53 were able to suppress AFP transcription and cause p21 induction; hSIR2, a negative regulator of the p53 protein, showed the opposite effects on the AFP promoter and, like HDAC1, repressed p21 promoter activity. In addition, we found that p33ING1b physically interacts with hSIR2, reverses its ability to induce the AFP promoter, and induces acetylation of p53 residues at Lys373 and/or Lys382. These findings provide novel evidence that p33ING1b represses AFP transcription by at least two mechanisms, one of which includes p53. The first is by binding to the AT-motif and excluding HNF1 binding while possibly targeting HAT activity to promoter regions, and the second is by increasing the levels of active, acetylated p53 via binding and inhibiting the ability of hSIR2 to deacetylate p53 protein.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. P. Sarker, H. Kataoka, A. Chan, S. J. Netherton, I. Pot, M. A. Huynh, X. Feng, A. Bonni, K. Riabowol, and S. Bonni
ING2 as a Novel Mediator of Transforming Growth Factor-{beta}-dependent Responses in Epithelial Cells
J. Biol. Chem., May 9, 2008; 283(19): 13269 - 13279.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Kumamoto, E. A. Spillare, K. Fujita, I. Horikawa, T. Yamashita, E. Appella, M. Nagashima, S. Takenoshita, J. Yokota, and C. C. Harris
Nutlin-3a Activates p53 to Both Down-regulate Inhibitor of Growth 2 and Up-regulate mir-34a, mir-34b, and mir-34c Expression, and Induce Senescence
Cancer Res., May 1, 2008; 68(9): 3193 - 3203.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Abad, C. Menendez, A. Fuchtbauer, M. Serrano, E.-M. Fuchtbauer, and I. Palmero
Ing1 Mediates p53 Accumulation and Chromatin Modification in Response to Oncogenic Stress
J. Biol. Chem., October 19, 2007; 282(42): 31060 - 31067.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. H. Coles, H. Liang, Z. Zhu, C. G.A. Marfella, J. Kang, A. N. Imbalzano, and S. N. Jones
Deletion of p37Ing1 in Mice Reveals a p53-Independent Role for Ing1 in the Suppression of Cell Proliferation, Apoptosis, and Tumorigenesis
Cancer Res., March 1, 2007; 67(5): 2054 - 2061.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Tang, M. Molina, and S. Amar
p53 Short Peptide (p53pep164) Regulates Lipopolysaccharide-Induced Tumor Necrosis Factor-{alpha} Factor/Cytokine Expression
Cancer Res., February 1, 2007; 67(3): 1308 - 1316.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
X. Feng, S. Bonni, and K. Riabowol
HSP70 Induction by ING Proteins Sensitizes Cells to Tumor Necrosis Factor Alpha Receptor-Mediated Apoptosis
Mol. Cell. Biol., December 15, 2006; 26(24): 9244 - 9255.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
W. Gong, M. Russell, K. Suzuki, and K. Riabowol
Subcellular Targeting of p33ING1b by Phosphorylation-Dependent 14-3-3 Binding Regulates p21WAF1 Expression
Mol. Cell. Biol., April 15, 2006; 26(8): 2947 - 2954.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
C.-G. Jung, H.-J. Kim, M. Kawaguchi, K. K. Khanna, H. Hida, K. Asai, H. Nishino, and Y. Miura
Homeotic factor ATBF1 induces the cell cycle arrest associated with neuronal differentiation
Development, December 1, 2005; 132(23): 5137 - 5145.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. Pedeux, S. Sengupta, J. C. Shen, O. N. Demidov, S. Saito, H. Onogi, K. Kumamoto, S. Wincovitch, S. H. Garfield, M. McMenamin, et al.
ING2 Regulates the Onset of Replicative Senescence by Induction of p300-Dependent p53 Acetylation
Mol. Cell. Biol., August 1, 2005; 25(15): 6639 - 6648.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. L. Gartel and S. K. Radhakrishnan
Lost in Transcription: p21 Repression, Mechanisms, and Consequences
Cancer Res., May 15, 2005; 65(10): 3980 - 3985.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
F. Goeman, D. Thormeyer, M. Abad, M. Serrano, O. Schmidt, I. Palmero, and A. Baniahmad
Growth Inhibition by the Tumor Suppressor p33ING1 in Immortalized and Primary Cells: Involvement of Two Silencing Domains and Effect of Ras
Mol. Cell. Biol., January 1, 2005; 25(1): 422 - 431.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.